Epstein-Barr virus DNA-guided chemoradiotherapy for patients with low-risk locoregionally advanced nasopharyngeal carcinoma: a secondary 5-year follow-up analysis of an open-label, randomised controlled, phase 2 non-inferiority trial
Epstein-Barr病毒DNA指导的放化疗治疗低危局部晚期鼻咽癌患者：一项开放标签、随机对照、II期非劣效性试验的5年随访二次分析
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103615
Li, Yu-Chen; Li, Xiao-Yun; Lan, Kai-Qi; Cheng, Hui; Chen, Jie; Liu, Li-Ting; Wen, Dong-Xiang; Gu, Li-Wen; Guo, Wan-Ping; Sun, Xue-Song; Liu, Sai-Lan; Yang, Jin-Hao; Li, Su-Chen; Li, Yi-Fu; Long, Hao-Xiang; Luo, Dong-Hua; Guo, Ling; Mo, Hao-Yuan; Sun, Rui; Guo, Shan-Shan; Wang, Pan; Li, Li-Bin; Yang, Qi; Liang, Yu-Jing; Jia, Guo-Dong; Yan, Jin-Jie; Zhao, Chong; Chen, Qiu-Yan; Li, Liang-Ji; Mai, Hai-Qiang; Tang, Lin-Quan
